GPNMB mitigates Alzheimer’s disease and enhances autophagy via suppress‐ ing the mTOR signal
GPNMB mitigates Alzheimer’s disease and enhances autophagy via suppress‐ ing the mTOR signal
复制标题
GPNMB 通过抑制 mTOR 信号减轻阿尔茨海默病并增强自噬
DOI:
10.1016/j.neulet.2021.136300
复制
发表时间:
2022
影响因子:
2.5
通讯作者:
赵丹玉
中科院分区:
文献类型:
--
作者:
朱仲康;刘羽茜;李新云;张林;刘慧慧;崔勇;王艳杰;赵丹玉
Alzheimer’s disease (AD) is a common neurodegenerative disease which is characterized by amyloid beta (Aβ) accumulation. We found that glycoprotein NMB (GPNMB) was highly expressed in the brain of APP/PS1 mice, a mouse model of AD. However, its role in AD remains unclear. In this study, we aimed to explore the function of GPNMB in AD. The expression of GPNMB in the brain was detected by immunofluorescence and western blot. In addition, the role of GPNMB in AD was explored through gain-of-function. Autophagy, which is beneficial to Aβ clearance, was evaluated by transmission electron microscope and immunofluorescence with beclin-1. Furthermore, 3-MA, an autophagy inhibitor, was employed to evidence whether GPNMB reduced the level of Aβ through autophagy. We found that over-expression of GPNMB improved AD-like behaviors in APP/PS1 mice and reduced Aβ deposition. Further study showed that GPNMB enhanced autophagy, reduced microglial cells and inhibited the activation of the mTOR signal. Additionally, treatment with 3-MA abolished the beneficial effect of GPNMB on Aβ clearance. This study revealed that the high level of GPNMB in AD brain may help Aβ clearance and improve AD-like behaviors through enhancing autophagy via suppressing the mTOR signal. This beneficial role of GPNMB provides us novel strategies for the prevention and treatment of AD.